News & Articles

Novogene Europe expands single-cell RNA sequencing services at its Cambridge Omics Centre to support advanced multiomics research

Read insights from an expert panel discussing the path towards making human-specific NAMs routine in preclinical research

FDA registration represents an important milestone in expanding access to the technology for healthcare professionals in the United States

Fapon debuts AI-engineered molecular diagnostic enzymes and Alzheimer's disease assay solutions while expanding its North American IVD footprint

Dr. Ben Murdock explains how flow cytometry is uncovering immune signatures in amyotrophic lateral sclerosis and how these could help guide new treatment strategies

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions

See why accessible, pathology-informed testing is becoming increasingly important for earlier diagnosis, patient stratification, and more efficient neurological care

Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market

SLAS Ignite Program offers emerging life science companies exhibition space, mentorship and funding support

Discover how compact, affordable liquid handling systems give core facilities, startups, and teaching labs reliable, walk-away precision

Study links elevated brain urea levels to frontotemporal dementia and ALS, suggesting a shared disease mechanism

Acquisition aims to support pathology laboratories in delivering faster, more reliable cancer diagnoses for patients

Novogene expands its Cambridge Omics Centre with new untargeted metabolomics capabilities.

SelectScience interviews leading experts at pivotal conference in London, UK

AI-powered fluorescence imaging predicts actionable lung cancer mutations without genetic testing

Cryopreserved human platelets to improve consistency in platelet-based research

Fujirebio Europe N.V. explains how the full integration of ADx NeuroSciences strengthens its end-to-end model for neurological biomarker development, from early discovery to routine clinical application

Comprehensive virus catalogue reveals two to three new human-infective viruses are identified annually, highlighting ongoing pandemic risks and the need for sustained global surveillance

Launches include the first commercially available singleplex eMTBR-Tau immunoassay, a novel pTau 217 assay for venous and capillary blood, and a fully automated instrument platform

New Vericheck ddPCR™ kits bring validated, ready-to-use quality control assays to the QX700™ Digital PCR platform

Combining proteomics with multiomics workflows is helping researchers move beyond single markers and toward a more connected view of immune dysregulation, patient subtypes, and disease activity

Targeted proteomics platform company secures $7.5 million to scale commercialization and strategic partnerships

Co-marketing agreement delivers end-to-end solution for DNA/RNA extraction and ultra-sensitive analysis

The test is being developed for use on Abbott’s Alinity ci-series systems to help enable earlier and more accessible Alzheimer’s diagnosis on a global scale

First-of-its-kind assay by Vector Laboratories and Spatomics enables simultaneous mapping of proteins and glycans on a single slide